HEADER    HYDROLASE/HYDROLASE INHIBITOR           25-JAN-00   1EBZ              
TITLE     HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388                   
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: HIV-1 PROTEASE;                                            
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 FRAGMENT: FRAGMENT 69-167;                                           
COMPND   5 EC: 3.4.23.16;                                                       
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 
SOURCE   3 ORGANISM_TAXID: 11676;                                               
SOURCE   4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   5 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   6 EXPRESSION_SYSTEM_PLASMID: PET11C                                    
KEYWDS    DIMER, PROTEIN-INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR       
KEYWDS   2 COMPLEX                                                              
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    T.UNGE                                                                
REVDAT   4   07-FEB-24 1EBZ    1       REMARK                                   
REVDAT   3   24-FEB-09 1EBZ    1       VERSN                                    
REVDAT   2   29-MAR-05 1EBZ    1       JRNL                                     
REVDAT   1   26-JUN-02 1EBZ    0                                                
JRNL        AUTH   H.O.ANDERSSON,K.FRIDBORG,S.LOWGREN,M.ALTERMAN,A.MUHLMAN,     
JRNL        AUTH 2 M.BJORSNE,N.GARG,I.KVARNSTROM,W.SCHAAL,B.CLASSON,A.KARLEN,   
JRNL        AUTH 3 U.H.DANIELSSON,G.AHLSEN,U.NILLROTH,L.VRANG,B.OBERG,          
JRNL        AUTH 4 B.SAMUELSSON,A.HALLBERG,T.UNGE                               
JRNL        TITL   OPTIMIZATION OF P1-P3 GROUPS IN SYMMETRIC AND ASYMMETRIC     
JRNL        TITL 2 HIV-1 PROTEASE INHIBITORS                                    
JRNL        REF    EUR.J.BIOCHEM.                V. 270  1746 2003              
JRNL        REFN                   ISSN 0014-2956                               
JRNL        PMID   12694187                                                     
JRNL        DOI    10.1046/J.1432-1033.2003.03533.X                             
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.01 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 0.9                                              
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : NULL                                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 24.60                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 1375945.910                    
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000                         
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 95.0                           
REMARK   3   NUMBER OF REFLECTIONS             : 15653                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.183                           
REMARK   3   FREE R VALUE                     : 0.208                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.000                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 785                             
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.007                           
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 6                            
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.01                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.14                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 90.40                        
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 2299                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2130                       
REMARK   3   BIN FREE R VALUE                    : 0.2280                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 5.40                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 130                          
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.020                        
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 1510                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 46                                      
REMARK   3   SOLVENT ATOMS            : 91                                      
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 8.00                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 21.10                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 3.51000                                              
REMARK   3    B22 (A**2) : -3.56000                                             
REMARK   3    B33 (A**2) : 0.05000                                              
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.21                            
REMARK   3   ESD FROM SIGMAA              (A) : 0.15                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.25                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.13                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.006                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.300                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 25.40                           
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.720                           
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.880 ; 1.500                
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 2.700 ; 2.000                
REMARK   3   SIDE-CHAIN BOND              (A**2) : 8.620 ; 2.000                
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 6.940 ; 2.500                
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : FLAT MODEL                                           
REMARK   3   KSOL        : 0.35                                                 
REMARK   3   BSOL        : 53.35                                                
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PA                                 
REMARK   3  PARAMETER FILE  2  : WATER_REP.PARA                                 
REMARK   3  PARAMETER FILE  3  : BEA388.PAR                                     
REMARK   3  PARAMETER FILE  4  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : PROTEIN.TOP                                    
REMARK   3  TOPOLOGY FILE  2   : BEA388.TOP                                     
REMARK   3  TOPOLOGY FILE  3   : NULL                                           
REMARK   3  TOPOLOGY FILE  4   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: REFINED WITH CNS PROGRAM SYSTEM           
REMARK   4                                                                      
REMARK   4 1EBZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JAN-00.                  
REMARK 100 THE DEPOSITION ID IS D_1000010442.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 08-JUL-97                          
REMARK 200  TEMPERATURE           (KELVIN) : 277                                
REMARK 200  PH                             : 5.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 4                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : LURE                               
REMARK 200  BEAMLINE                       : D41A                               
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.375                              
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH                        
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 15653                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.010                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 24.600                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 1.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 95.0                               
REMARK 200  DATA REDUNDANCY                : 3.600                              
REMARK 200  R MERGE                    (I) : 0.07200                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 7.9000                             
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.14                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 90.4                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 1.50                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.20300                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL                         
REMARK 200 SOFTWARE USED: X-PLOR                                                
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 55.52                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.4 M SODIUM CHLORIDE, 0.05 M MES,       
REMARK 280  0.02 % (W/V) SODIUM AZIDE, PH 5.5, VAPOR DIFFUSION, HANGING DROP,   
REMARK 280  TEMPERATURE 277K                                                    
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2                        
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,-Y,Z                                                 
REMARK 290       3555   -X+1/2,Y+1/2,-Z                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000       29.42000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       43.33000            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       29.42000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       43.33000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A DIMER                           
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 5080 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 9070 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     ARG A  41    CG   CD   NE   CZ   NH1  NH2                        
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEC B 501                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1AJV   RELATED DB: PDB                                   
REMARK 900 1AJV CONTAINS THE SAME PROTEIN COMPLEXED WITH THE CYCLIC SULFAMIDE   
REMARK 900 INHIBITOR AHA006                                                     
REMARK 900 RELATED ID: 1AJX   RELATED DB: PDB                                   
REMARK 900 1AJX CONTAINS THE SAME PROTEIN COMPLEXED WITH THE CYCLIC UREA        
REMARK 900 INHIBITOR AHA001                                                     
REMARK 900 RELATED ID: 1D4I   RELATED DB: PDB                                   
REMARK 900 1D4I CONTAINS THE SAME PROTEIN COMPLEXED WITH THE INHIBITOR BEA425   
REMARK 900 RELATED ID: 1D4H   RELATED DB: PDB                                   
REMARK 900 1D4H CONTAINS THE SAME PROTEIN COMPLEXED WITH THE INHIBITOR BEA435   
REMARK 900 RELATED ID: 1D4J   RELATED DB: PDB                                   
REMARK 900 1D4J CONTAINS THE SAME PROTEIN COMPLEXED WITH THE INHIBITOR MSL370   
REMARK 900 RELATED ID: 1EBW   RELATED DB: PDB                                   
REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322                  
REMARK 900 RELATED ID: 1EBY   RELATED DB: PDB                                   
REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369                  
REMARK 900 RELATED ID: 1EC0   RELATED DB: PDB                                   
REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403                  
REMARK 900 RELATED ID: 1EC1   RELATED DB: PDB                                   
REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409                  
REMARK 900 RELATED ID: 1EC2   RELATED DB: PDB                                   
REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428                  
REMARK 900 RELATED ID: 1EC3   RELATED DB: PDB                                   
REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367                  
DBREF  1EBZ A    1    99  UNP    P03366   POL_HV1B1       69    167             
DBREF  1EBZ B  101   199  UNP    P03366   POL_HV1B1       69    167             
SEQRES   1 A   99  PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE          
SEQRES   2 A   99  LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 A   99  GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO          
SEQRES   4 A   99  GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY          
SEQRES   5 A   99  PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU          
SEQRES   6 A   99  ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 A   99  PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR          
SEQRES   8 A   99  GLN ILE GLY CYS THR LEU ASN PHE                              
SEQRES   1 B   99  PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE          
SEQRES   2 B   99  LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 B   99  GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO          
SEQRES   4 B   99  GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY          
SEQRES   5 B   99  PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU          
SEQRES   6 B   99  ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 B   99  PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR          
SEQRES   8 B   99  GLN ILE GLY CYS THR LEU ASN PHE                              
HET    BEC  B 501      46                                                       
HETNAM     BEC [5-(2-HYDROXY-INDAN-1-YLCARBAMOYL)-3,4-DIHYDROXY-2,5-            
HETNAM   2 BEC  [DIBENZYL-OXY]-PENTANOYL]-VALINYL-AMIDO-METHANE                 
HETSYN     BEC INHIBITOR BEA388                                                 
FORMUL   3  BEC    C35 H43 N3 O8                                                
FORMUL   4  HOH   *91(H2 O)                                                     
HELIX    1   1 GLY A   86  THR A   91  1                                   6    
HELIX    2   2 GLN A   92  GLY A   94  5                                   3    
HELIX    3   3 GLY B  186  THR B  191  1                                   6    
SHEET    1   A 4 GLN A   2  ILE A   3  0                                        
SHEET    2   A 4 THR B 196  ASN B 198 -1  O  LEU B 197   N  ILE A   3           
SHEET    3   A 4 THR A  96  ASN A  98 -1  N  THR A  96   O  ASN B 198           
SHEET    4   A 4 GLN B 102  ILE B 103 -1  N  ILE B 103   O  LEU A  97           
SHEET    1   B 8 LYS A  43  GLY A  49  0                                        
SHEET    2   B 8 GLY A  52  ILE A  66 -1  O  GLY A  52   N  GLY A  49           
SHEET    3   B 8 LEU A  10  ILE A  15 -1  O  LYS A  14   N  GLU A  65           
SHEET    4   B 8 GLN A  18  LEU A  24 -1  O  GLN A  18   N  ILE A  15           
SHEET    5   B 8 ILE A  84  ILE A  85  1  N  ILE A  85   O  LEU A  23           
SHEET    6   B 8 VAL A  32  LEU A  33 -1  O  VAL A  32   N  ILE A  84           
SHEET    7   B 8 HIS A  69  VAL A  77  1  O  LEU A  76   N  LEU A  33           
SHEET    8   B 8 GLY A  52  ILE A  66 -1  N  ARG A  57   O  VAL A  77           
SHEET    1   C 8 LYS B 143  GLY B 149  0                                        
SHEET    2   C 8 GLY B 152  ILE B 166 -1  O  GLY B 152   N  GLY B 149           
SHEET    3   C 8 LEU B 110  ILE B 115 -1  O  LYS B 114   N  GLU B 165           
SHEET    4   C 8 GLN B 118  LEU B 124 -1  O  GLN B 118   N  ILE B 115           
SHEET    5   C 8 ILE B 184  ILE B 185  1  N  ILE B 185   O  LEU B 123           
SHEET    6   C 8 VAL B 132  LEU B 133 -1  O  VAL B 132   N  ILE B 184           
SHEET    7   C 8 HIS B 169  VAL B 177  1  O  LEU B 176   N  LEU B 133           
SHEET    8   C 8 GLY B 152  ILE B 166 -1  N  ARG B 157   O  VAL B 177           
SITE     1 AC1 25 ARG A   8  LEU A  23  ASP A  25  GLY A  27                    
SITE     2 AC1 25 ALA A  28  ASP A  29  GLY A  48  GLY A  49                    
SITE     3 AC1 25 PRO A  81  VAL A  82  ILE A  84  HOH A 313                    
SITE     4 AC1 25 ARG B 108  ASP B 125  GLY B 127  ALA B 128                    
SITE     5 AC1 25 ASP B 129  ASP B 130  VAL B 132  GLY B 148                    
SITE     6 AC1 25 GLY B 149  PRO B 181  VAL B 182  ILE B 184                    
SITE     7 AC1 25 HOH B 322                                                     
CRYST1   58.840   86.660   46.870  90.00  90.00  90.00 P 21 21 2     8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.017007  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.011534  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.021322        0.00000